Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$12.4 - $17.6 $132,915 - $188,654
-10,719 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$11.59 - $14.93 $80,446 - $103,629
-6,941 Reduced 39.3%
10,719 $142,000
Q2 2020

Aug 17, 2020

SELL
$11.79 - $15.97 $220,284 - $298,383
-18,684 Reduced 51.41%
17,660 $221,000
Q1 2020

May 15, 2020

BUY
$9.31 - $21.24 $216,308 - $493,490
23,234 Added 177.22%
36,344 $488,000
Q4 2019

Feb 14, 2020

BUY
$13.91 - $21.48 $10,279 - $15,873
739 Added 5.97%
13,110 $262,000
Q3 2019

Nov 14, 2019

BUY
$15.84 - $30.01 $195,956 - $371,253
12,371 New
12,371 $197,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $329M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.